Laboratories Oversight Board 14th March 2019 Programme Performance Update – Reporting Period 23/01/19 to 07/03/19

Regular Update Items Key Highlights Programme Budget Programme Metrics Key Risks & Issues Stakeholder Engagement Key Milestones Change Control Requests Project Updates

Blueprint Development Engagement & Communications Key Highlights IT Connectivity NLIIP Completion of final report for Proof of Concept with recommendations for preferred way forward for phase 1 Further demos of dashboard to West region and West Region Laboratories Board Engagement with stakeholders on preferred way forward Start up meeting complete at NHS Highland. Induction meetings with Golden Jubilee Hospital and NHS Lanarkshire User acceptance training progressing in Borders NPEx roadshow event planning Exploratory meeting for NPEx applicability to supporting TB testing Notable Highlights Blueprint Development Engagement & Communications Workshop delivered with North region and draft priorities TB Diagnosis Options Business Case reviewed by Blueprint Subgroup for alignment with Blueprint Standardisation group being established after agreement from LOB and regions Labs website now live Joint planning for engagement event in NHS Fife 22/03/19 Initial meeting with Access Collaborative Results plus meeting

Key Programme Metrics @ 7th March 2019 Stakeholder Engagement Programme Budget Programme Resources Overall Programme Status Benefits Realisation Programme Schedule Programme Leadership

Programme Metrics Commentary Explanatory Commentary Stakeholder engagement (G) Stakeholder engagement continuing through the regional groups, networks, IG leads and eHealth leads. Local stakeholder events taken place in North region and being planned in the East region. Programme Budget (R) Metric is currently red as per last report with current year end forecast position with an underspend of approximately £380k due to further delay in slower mobilisation than anticipated and additional delays in NPEx deployments. Conversations are ongoing regarding the ability to bid for the carry forward of underdspend monies into 19/20. The programme metric tolerance position of >5% places this metric at red. Programme Resources (A) Metric remains at amber as per previous report, core programme team currently have a vacancy for a Programme Director. The role is now being advertised with closing date of 22/03/19. Benefits Realisation (G) Committed business case benefits are to be realised from year 2 (19/20) onwards. Current activity focuses on the development of a benefits methodology and approach for presentation to the LOB in March. Programme Schedule (A) Programme plan remains at amber with pressure on timescales for NPEx deployments specifically obtaining information governance approval from NHS Ayrshire and Arran and a set up risk with NHS Forth Valley creating delays. Start dates are not yet confirmed for either of these Boards. Programme Leadership (A) Metric remains at amber due to Labs Programme Director vacancy however interim arrangements are working well with support from NSS Healthcare Science Director and Portfolio Manager. Overall Programme (A) Overall, subjective, metric stays at amber consistent with last performance report. This is due to delays in NPEx deployment, underspend on budget and pressures coming through on other key milestones. Positive progress made in final report for NLIIP proof of concept, organisational readiness for Boards deploying NPEx in tranche 3, stakeholder engagement, developing national roadmap and strengthening programme governance through standardisation group and DSM clinical leads group.

Change Control Requests & Decisions Requests @ 7th March 2019 0 Changes 1 business case received from DSG

Stakeholder Engagement & Communications F2F engagement Social media on hold Laboratory staff engagement sessions planned with East Region 22/03/19 Programme website has gone live Newsletter circulated Leaflet produced Access Collaborative,

Risks, Issues & Dependencies Summary Risks Issues Red 4 Amber Green 2 1 Issues IG sign off on data sharing agreement for NHS Forth Valley Configuration of VPN tunnel NHS Shetland Conflict between the IP address ranges used at Forth Valley (192.xx.xx.xx) and those utilised by THIS Current Forth Valley infrastructure cannot facilitate the required VPN connection for NPEx

Project Status Updates IT Connectivity Delivery Project 1 National Laboratories Intelligence & Information Platform Delivery Project 2 Blueprint Development & Benefits Workstream 3

IT Connectivity Project This Period Last Period Amber Start up meeting with NHS Highland Introductory meetings with NHS Lanarkshire, Golden Jubilee Hospital IG sign off NHS Shetland NHS Borders pipe clean testing NPEx roadshow planning Exploratory discussion with Xlabs re applicability of NPEx to TB testing requests Delivered this period IG sign off NHS Ayrshire and Arran, NHS Orkney Rescheduling of NHS Forth Valley deployment Technical connectivity issues with NHS Forth Valley Challenges Actions for next period Complete expansion plan for all Boards NHS Borders move to testing in live environment IG sign off NHS Ayrshire and Arran and NHS Orkney and commence deployment Solution for technical connectivity issue with NHS Forth Valley Complete organisational readiness and deployment initiation with NHS Shetland

National Laboratories Intelligence & Information Platform Project This Period Last Period Amber Green National Laboratories Intelligence & Information Platform Project Delivered this period Agreeing approach for phase 1 development Challenges Agree discipline priorities for phase 1 development of LOB Produce plan for delivery of phase 1 Commence development activity for phase 1 Actions for next period Profile NHS Borders data and add to dashboard Final report produced Focus group with West region Engagement sessions with remaining Boards Learning session with SNBTS and SCI store

Blueprint Development & Benefits Workstream This Period Last Period Green Amber Blueprint Development & Benefits Workstream Delivered this period Communicating the Blueprint more widely with Laboratories stakeholders Governance of operational improvements vs. service transformation Challenges Actions for next period Further development of roadmap and action plans Agreed date, structure for West region workshop First meeting of DSM Clinical Leads Subgroup First meeting of Standardisation Subgroup North region workshop delivered with priority outputs Draft national roadmap of priorities ToR produced for standardisation Subgroup ToR produced for DSM Clinical Leads Subgroup Assessment of C-peptide testing and subsequent antibody and genetic testing Business Case against Blueprint alignment tool

Next LABORATORIES Oversight Board – 23 April 2019 Next LABORATORIES Oversight Board – 23 April